Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Sales | 10,363,240 | 9,769,600 | 9,537,750 | 9,561,350 | 9,951,378 |
| Cost of Goods | 2,380,240 | 2,095,000 | 2,071,000 | 2,129,000 | 2,533,000 |
| Gross Profit | 8,464,609 | 7,586,000 | 7,334,000 | 7,383,000 | 9,181,000 |
| Operating Expenses | 5,527,140 | 4,755,000 | 4,272,000 | 4,359,000 | 6,239,000 |
| Operating Income | 2,456,100 | 2,919,600 | 3,194,750 | 3,073,350 | 1,179,378 |
| Interest Expense | -591,000 | 200,000 | 206,000 | 185,000 | 113,000 |
| Other Income | -102,130 | 382,400 | -8,750 | 343,650 | 2,066,622 |
| Pre-tax Income | 2,944,970 | 3,102,000 | 2,980,000 | 3,232,000 | 3,133,000 |
| Income Tax | 834,030 | 885,000 | 848,000 | 922,000 | 897,000 |
| Net Income Continuous | 2,019,300 | 2,237,480 | 2,161,700 | 2,321,990 | 1,793,226 |
| Net Income | $2,019,300 | $2,237,480 | $2,161,700 | $2,321,990 | $1,793,226 |
| EPS Basic Total Ops | 0.86 | 0.95 | 0.93 | 1.00 | 0.79 |
| EPS Basic Continuous Ops | 0.87 | 0.95 | 0.93 | 1.00 | 0.79 |
| EPS Diluted Total Ops | 0.85 | 0.94 | 0.91 | 1.00 | 0.79 |
| EPS Diluted Continuous Ops | 0.87 | 0.95 | 0.93 | 1.00 | 0.79 |
| EBITDA(a) | $1,272,100 | $3,357,600 | $3,662,750 | $3,351,350 | $1,179,378 |